IXC 0.00% 6.5¢ invex therapeutics ltd

They're very much pushing the combined trial strategy. A risk,...

  1. 190 Posts.
    lightbulb Created with Sketch. 22
    They're very much pushing the combined trial strategy.

    A risk, in the sense that the companies SP narrative is tied to the success of that.

    I really hope it works, and if it does I can see the SP taking off, but if it backfires, then we are in for more pain...

    Cash burn is very impressive, run on an oily rag, so I feel confident that management are giving this every chance of success and that it isn't just some director fee play thing.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.